Home›Search›Recent Advances in Inflammation and Allergy Drug Discovery

Recent Advances in Inflammation and Allergy Drug Discovery

Bentham Science Publishers · United Arab Emirates · Est. 2006

ISSN2772-2716

SJR Q3✓ WOS ESCI✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS ESCI56

✓ Corroboration (2 more)+12

Total68

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 75% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

Find the journal’s official page ↗Open the official JCR record on Clarivate ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.391

H-Indexi

SNIPi

0.34

Total Worksi

142

Total Citationsi

309

2yr Mean Citednessi

0.90

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Recent Advances in Inflammation and Allergy Drug Discovery is an international, peer-reviewed journal covering all aspects of inflammation and allergy research. It publishes articles on important and recent patents in the field, and is essential reading for researchers involved in inflammation and allergy drug design and discovery.

AI-compiled from public web sources · verify on the publisher page

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published2006

Annual Volume~ 30 articles / year

StatusActive (last: 2026)

Total Publications142

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/12 · 42%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2772-2716

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2006

2012

2021

172

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ3

Immunology and AllergyQ3

Pharmacology (medical)Q3

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Drug DiscoveryImmunology and Allergy

Research Topics (OpenAlex)

Diverse Scientific and Economic StudiesPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesPharmacological Effects of Natural CompoundsCOVID-19 Clinical Research StudiesAsthma and respiratory diseasesCinema and Media StudiesAdvanced Drug Delivery SystemsEcocriticism and Environmental LiteratureSouth Asian Cinema and Culture

Frequently asked questions about Recent Advances in Inflammation and Allergy Drug Discovery

Is Recent Advances in Inflammation and Allergy Drug Discovery a predatory journal?

PubScope has no integrity flags on record for Recent Advances in Inflammation and Allergy Drug Discovery: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 68/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Recent Advances in Inflammation and Allergy Drug Discovery?

Recent Advances in Inflammation and Allergy Drug Discovery is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.90.

Is Recent Advances in Inflammation and Allergy Drug Discovery indexed in Scopus and Web of Science?

Recent Advances in Inflammation and Allergy Drug Discovery is indexed in Web of Science, Scopus.